Powell

Researchers are evaluating the effectiveness and safety of Corabotase IPN10200 in adults with moderate to severe glabellar lines, which are wrinkle-like lines between the eyebrows that may affect appearance and confidence. This Phase III study compares a single dose of Corabotase to a placebo in a double-blind phase, followed by an open-label phase to assess repeat doses over time. Participants will receive injections of Corabotase or placebo into selected facial muscles. The study includes a screening period of up to 20 days, a treatment period with up to four treatment cycles where participants may receive Corabotase or placebo in the double-blind phase and Corabotase in the open-label phase, and a follow-up period lasting 24 weeks after the last injection. Multiple visits occur during the first month of treatment, followed by monthly visits. During the study, participants will have health assessments including blood tests, physical exams, ECGs, questionnaires, and diaries. Researchers will measure treatment response at week 4 and monitor safety and satisfaction through week 104. Total participation lasts up to 107 weeks, and participants may withdraw at any time.

Researchers are evaluating the Balanced Progressive Intensity Training BPIT 5-Line Principle, a 5-week supervised exercise program designed for healthy adults aged 18 to 65 years. The study focuses on how this training method influences functional movement efficiency, joint mobility, postural control, strength adaptation, and heart rate variability while tracking safety and individual responses to exercise intensity. Participants will engage in 3 to 5 supervised BPIT sessions per week, progressing through five levels of intensity based on anatomical landmarks and ground reaction forces. These levels include Ground-Based Low, Knee-Level Low-Moderate, Standing Moderate, Head-Level Moderate-High, and Plyometric High-Impact training. The entire program lasts five weeks, applying a structured increase in exercise challenge. Throughout the study, participants will undergo assessments at baseline and after five weeks, including functional movement screening, balance tests, strength measures, joint range of motion, and pain evaluation. Weekly monitoring will track resting heart rate variability and any training-related discomfort or minor injuries. The study aims to measure improvements in movement efficiency and neuromuscular adaptation while ensuring participant safety during the training period.